Prostate News Archive
08-Nov-2006
Cytogen Presents Positive Research on Prostate Cancer (RedNova)
Cytogen has presented positive results from a phase I clinical trial of Quadramet in combination with hormonal and radiation therapy in prostate cancer patients. Data from the study indicate that the combination regimen was well tolerated with preliminary anti-tumor activity observed. A Gentler Prostate Cancer Therapy (CBS News)
A new study suggests that some men who take hormone therapy for prostate cancer for more than six months do not live as long as those treated a shorter time. Screening: Findings Suggest Need to Rethink Prostate Tests (New York Times)
A new report suggests that doctors should reconsider when and how often they test men for a prostate cancer marker.
Back to Prostate News Archive
